MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2024-12-31.

Income Overview

Net Income
-$25,951K
EPS
-$1.54
Unit: Thousand (K) dollars

Income Statement
2024-12-31
Research and development
13,006
Impairment of long-lived assets
2,705
General and administrative
15,460
Total operating expenses
31,171
Loss from operations
-31,171
Other expense, net
-265
Interest income
1,733
Gain on warrant liability
3,713
Net loss
-25,990
Unrealized gain (loss) on marketable debt securities
39
Comprehensive loss
-25,951
Basic EPS
-1.54
Diluted EPS
-1.54
Basic Average Shares
16,827,038
Diluted Average Shares
16,827,038
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$25,951K Unrealized gain (loss) onmarketable debt securities$39K Net loss-$25,990K Gain on warrantliability$3,713K Interest income$1,733K Loss from operations-$31,171K Other expense, net-$265K Total operatingexpenses$31,171K General andadministrative$15,460K Research and development$13,006K Impairment of long-livedassets$2,705K

Unity Biotechnology, Inc. (UBX)

Unity Biotechnology, Inc. (UBX)